Skip to main content
. 2015 May 20;10(5):e0128360. doi: 10.1371/journal.pone.0128360

Fig 6. Total binding free energies of the mutant-inhibitor or mutant-partner systems, involving several specific mutants.

Fig 6

(a), The total binding free energies between several important EGFR kinases (WT, L858R, L858R_T890M) and a dimerization partner (ErbB-2, IGF-1R, c-Met) or an inhibitor (gefitinib, erlotinib). (b) to (f), Ranked binding free energies for the systems regarding all of our mutants (37 types + WT + L858R_T790M) in an ascending order.